Risedronate, and its phosphonocarboxylate analogue NE10790, both induce apoptosis, but have differential effects on the cell cycle and protein prenylation in human myeloma cells.

Samankaltaisia teoksia

• NE10790, a phosphonocarboxylate analogue of risedronate, induces human myeloma cell apoptosis in vitro
  Tekijä: Roelofs, A, et al.
  Julkaistu: (2004)
• Selective inhibition of Rab prenylation by a phosphonocarboxylate analogue of risedronate induces apoptosis, but not S-phase arrest, in human myeloma cells.
  Tekijä: Roelofs, A, et al.
  Julkaistu: (2006)
• Studies to elucidate the anti-tumor mechanism of action of risedronate in human myeloma cells; Use of an analogue of risedronate reveals the effects of differential inhibition of prenylation
  Tekijä: Roelofs, A, et al.
  Julkaistu: (2005)
• Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate.
  Tekijä: Marma, MS, et al.
  Julkaistu: (2007)
• The bisphosphonate-ester apornine does not act by inhibiting protein prenylation, but enhances the effects of lovastatin on myeloma cells
  Tekijä: Roelofs, A, et al.
  Julkaistu: (2006)